![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Parabolic Drugs Limited Panchkula District In, based in India, is a pharmaceutical company that stands out with its certifications from EDQM and WHO-GMP.
One of their significant offerings is Pivampicillin, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2009-295 - Rev 00
This Chemical Type CEP, issued on June 01, 2011, remains in force until July 29, 2015, ensuring its reliability within the pharmaceutical industry.
Substance Number 852 associated with this CEP further emphasizes